Oak Hill Wealth Advisors LLC Buys Shares of 4,319 CVS Health Corporation (NYSE:CVS)

Oak Hill Wealth Advisors LLC bought a new stake in CVS Health Corporation (NYSE:CVS) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,319 shares of the pharmacy operator’s stock, valued at approximately $293,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Dodge & Cox grew its stake in CVS Health by 11.2% in the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator’s stock valued at $3,147,054,000 after purchasing an additional 7,075,209 shares in the last quarter. Capital World Investors grew its stake in CVS Health by 26.6% in the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator’s stock valued at $2,739,927,000 after purchasing an additional 12,819,148 shares in the last quarter. Geode Capital Management LLC grew its stake in CVS Health by 2.6% in the fourth quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator’s stock valued at $1,211,582,000 after purchasing an additional 689,867 shares in the last quarter. Capital International Investors grew its stake in CVS Health by 4.8% in the fourth quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator’s stock valued at $1,196,989,000 after purchasing an additional 1,212,126 shares in the last quarter. Finally, Pzena Investment Management LLC grew its stake in CVS Health by 49.3% in the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator’s stock valued at $880,319,000 after purchasing an additional 6,475,271 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS stock opened at $66.44 on Thursday. The stock has a 50 day moving average of $64.81 and a two-hundred day moving average of $60.62. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a market capitalization of $84.05 billion, a P/E ratio of 15.86, a P/E/G ratio of 0.97 and a beta of 0.56.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the company earned $1.31 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. As a group, equities analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the company. Mizuho upped their price target on CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Piper Sandler upped their price target on CVS Health from $72.00 to $74.00 and gave the stock an “overweight” rating in a research note on Friday, March 21st. Royal Bank Of Canada upped their price target on CVS Health from $74.00 to $81.00 and gave the stock an “outperform” rating in a research note on Monday, May 5th. Morgan Stanley reaffirmed an “overweight” rating on shares of CVS Health in a report on Tuesday, April 15th. Finally, Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $74.75.

Insider Buying and Selling

In related news, Director Guy P. Sansone bought 1,570 shares of the business’s stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director now directly owns 12,007 shares of the company’s stock, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.22% of the stock is owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.